Dare Bioscience, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Dare Bioscience, Inc. (DARE) had Lessee, Operating Lease, Liability, to be Paid, Year One of $583.05 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $583.05K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $583.05K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $680.08K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $680.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $583.05K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $583.05K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $680.08K 10-K · filed 2026-03-26 |
| 2025-09-30 | $680.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $680.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $680.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $660.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $660.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $660.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $660.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $592.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $93.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $93.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $93.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $422.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $422.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $422.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $422.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $277.70K 10-K · filed 2022-03-31 |
| 2021-09-30 | $278.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $277.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $278.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $363.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $363.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $363.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $334.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $461.00K 10-K · filed 2020-03-27 |
| 2019-09-30 | $27.66K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $55.53K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $81.95K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |